USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
Increasing Applications of Biomarkers are Driving Growth
RELEASE DATE
13-Jun-2014
13-Jun-2014
REGION
North America
North America
Research Code: MA01-01-00-00-00
SKU: LS00097-NA-MR_16938
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
LS00097-NA-MR_16938
Description
Biomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends and dynamics are analysed in this study. This research service offers market overview, Market Engineering measurements, revenue forecasts, company profiling and key trends for the market and its segments, namely, genomics, proteomics, metabolomics and imaging biomarkers.
Table of Contents
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Market Attractiveness by Region
3 Big Predictions
Market Background
Market Overview
Market Segmentation
Market Segmentation (continued)
Defining Future Healthcare Trends
New Market Opportunities
New Market Opportunities (continued)
Merger, Acquisition and Partnership Assessment
Merger, Acquisition and Partnership Assessment (continued)
Market Drivers
Market Restraints
Impact Mapping of Drivers and Restraints
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast Discussion
Per cent Revenue Forecast by Segment
Revenue Forecast by Segment
Biomarkers Market Outlook in Europe
Per cent Revenue by Region
Technology Trends
Market Trends
Emerging Trends
Emerging Trends (continued)
Emerging Trends (continued)
Technology Lifecycle Analysis
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Genomics Segment—Metrics Analysis
Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics
Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics (continued)
Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Proteomics Segment—Metrics Analysis
Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics
Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)
Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)
Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast discussion
Revenue Forecast Discussion (continued)
Metabolomics Segment—Metrics Analysis
Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics
Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics (continued)
Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics (continued)
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Imaging Segment—Metrics Analysis
Growth Opportunity Analysis for Imaging in Drug Discovery and Companion Diagnostics
Growth Opportunity Analysis for Imaging in Drug Discovery and Companion Diagnostics (continued)
UK Biobank
UK Biobank (continued)
UK Biobank (continued)
UK Biobank (continued)
UK Biobank (continued)
The Biomarkers Consortium
The Biomarkers Consortium (continued)
The Biomarkers Consortium (continued)
Other Biomarker Research Projects
Other Biomarker Research Projects (continued)
Market Attractiveness by Region
Regional Analysis—The United Kingdom
Regional Analysis—Germany
Regional Analysis—France
Regional Analysis—Italy
Regional Analysis—Spain
Regional Analysis—Benelux
Regional Analysis—Scandinavia
Aepodia S.A.
Affymetrix
Almac Group
Argutus Medical Limited (EKF Diagnostics Group)
AROS Applied Biotechnology A/S
Bio-Rad Laboratories, Inc.
BioSystems International
Biovica International AB
Diagenic ASA
DNAVision SA
Epigenomics AG
Epistem Plc
Eurofins Scientific
Indivumed GmbH
Metabometrix
Pronota NV
Protagen AG
Proteome Sciences
ProteoSys AG
QIAGEN
Roche
Thermo Fisher Scientific
The Last Word—3 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
List of Other Companies in Biomarkers Research, Development and/or Services
List of Other Companies in Biomarkers Research, Development and/or Services (continued)
List of Other Companies in Biomarkers Research, Development and/or Services (continued)
Decision Support Database
Decision Support Database (continued)
Decision Support Database (continued)
Additional Sources of Information on Diabetes
Market Engineering Methodology
Learn More—Next Steps
Popular Topics
This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial timelines and results, key market developments, historical and projected launch timelines, and epidemiology. The information contained in this research was derived from published sources, including disease organizations; public health organizations; company publications including annual reports, SEC filings, and press releases; government public sources; and articles in scientific journals.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Srinivas Sashidhar |
| WIP Number | MA01-01-00-00-00 |
| Is Prebook | No |